"10.1371_journal.pone.0113705","plos one","2015-01-28T00:00:00Z","Ola Fjellstr√∂m; Sibel Akkaya; Hans-Georg Beisel; Per-Olof Eriksson; Karl Erixon; David Gustafsson; Ulrik Jurva; Daiwu Kang; David Karis; Wolfgang Knecht; Viveca Nerme; Ingemar Nilsson; Thomas Olsson; Alma Redzic; Robert Roth; Jenny Sandmark; Anna Tigerstr√∂m; Linda √ñster","Medicinal Chemistry, Cardiovascular & Metabolic Diseases Innovative Medicines, AstraZeneca R&D, M√∂lndal, Sweden; Discovery Sciences, AstraZeneca R&D, M√∂lndal, Sweden; Bioscience, Cardiovascular & Metabolic Diseases Innovative Medicines, AstraZeneca R&D, M√∂lndal, Sweden; Drug Metabolism and Pharmacokinetics, Cardiovascular & Metabolic Diseases Innovative Medicines, AstraZeneca R&D, M√∂lndal, Sweden","Conceived and designed the experiments: OF SA HGB POE KE DG UJ D. Kang D. Karis WK VN IN TO AR RR JS AT LO. Performed the experiments: SA HGB POE KE UJ D. Karis WK IN TO AR RR JS AT LO. Analyzed the data: OF SA HGB POE KE DG UJ D. Kang D. Karis WK VN IN TO AR RR JS AT LO. Contributed reagents/materials/analysis tools: SA KE D. Karis AR RR. Wrote the paper: OF HGB POE DG UJ D. Kang D. Karis WK VN IN TO JS AT.","The authors have read the journal‚Äôs policy and have the following competing interests: All authors are, or were, employees of AstraZeneca. This does not alter adherence to PLOS ONE policies on sharing data and materials.","2015","01","Ola Fjellstr√∂m","OF√",18,TRUE,8,6,8,6,TRUE,TRUE,TRUE,9,"10;11;12;13;14;15;16;17;18",TRUE
